2024
DOI: 10.1101/2024.02.07.24302418
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Expanding the mutational spectrum ofGCKin Turkish pediatric population

Vehap Topcu,
Gonul Buyukyilmaz,
Keziban Toksoy Adiguzel
et al.

Abstract: Glucokinase (GCK) is a central enzyme that keeps integrity of glucose metabolism. Heterozygous loss-of-function variants in GCK cause persistent, mildly elevated plasma glucose beginning at birth. Recently, clinical phenotype created by deleterious variants in GCK is called GCK-MODY, although currently registered as MODY, type 2 (maturity-onset diabetes of the young type 2, MODY2, MIM # 125851) in OMIM. Severity of clinical phenotype is consistent among patients due to the compensation from the unaffected alle… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 38 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?